For the quarter ending 2025-09-30, UAMY had $12,661,657 increase in cash & cash equivalents over the period. -$12,538,871 in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -4,780,700 | 728,079 |
| Depreciation and amortization | 279,828 | 559,525 |
| Accretion of asset retirement obligation | 19,482 | 38,967 |
| Noncash operating lease expense | 45,032 | 244,510 |
| Share-based compensation | 3,856,475 | 832,297 |
| Accretion income from investment securities held to maturity | -126,450 | -95,990 |
| (gain) loss on sale or disposal of property, plant and equipment, net | 8,716 | - |
| Gain on lease termination | 469,822 | - |
| Change in allowance for credit losses | 4,914 | 884 |
| Accounts receivable | -583,522 | 1,387,733 |
| Inventories | 1,600,634 | 5,566,803 |
| Accounts payable | - | 4,201,001 |
| Prepaid expenses and other current assets | 477,248 | 1,249,047 |
| Iva receivable and other assets, net | 16,768 | 483,360 |
| Accounts payable | 2,672,335 | - |
| Other noncash items | - | 0 |
| (gain) loss on sale or disposal of property, plant and equipment, net | - | -500 |
| Accrued liabilities | 329,849 | -175,368 |
| Write-down of inventory to net realizable value | - | 0 |
| Accrued liabilities - directors | 780 | -52,537 |
| Royalties payable | 24,922 | 49,089 |
| Net cash (used in) provided by operating activities | -3,863,700 | -2,356,986 |
| Purchases of investment securities held to maturity | 9,943,694 | 9,991,259 |
| Proceeds from sales of property, plant and equipment | 8,216 | 500 |
| Proceeds from redemption of certificates of deposit | - | 0 |
| Purchases of property, plant and equipment | 8,675,171 | 7,394,073 |
| Net cash (used in) provided by investing activities | -18,610,649 | -17,384,832 |
| Principal payments on long-term debt | 33,206 | 65,550 |
| Proceeds from exercises of stock options | 0 | 55,000 |
| Proceeds from exercise of warrants | - | 2,225,411 |
| Treasury stock acquired | 409,246 | - |
| Proceeds from issuance of common stock, net of issuance costs | 33,376,113 | 5,064,483 |
| Proceeds from exercise of warrants | 4,427,756 | - |
| Net cash provided by (used in) financing activities | 35,136,006 | 7,279,344 |
| Net increase in cash and cash equivalents and restricted cash | 12,661,657 | -12,462,474 |
| Cash and cash equivalents at beginning of period | 18,270,898 | - |
| Cash and cash equivalents at end of period | 18,470,081 | - |
UNITED STATES ANTIMONY CORP (UAMY)
UNITED STATES ANTIMONY CORP (UAMY)